Hospira Names Zena G. Kaufman Senior Vice President Of Quality; Strengthens Quality And Compliance Capabilities With Addition Of Top Industry Talent

LAKE FOREST, Ill., Feb. 13, 2012 /PRNewswire/ -- Hospira, Inc. (NYSE: HSP), the world's leading provider of injectable drugs and infusion technologies, today announced the hiring of several new leaders to strengthen the company's quality and compliance capabilities, including the appointment of Zena G. Kaufman as senior vice president, Quality, effective Feb. 27, 2012. In this role, Ms. Kaufman will have overall responsibility for Hospira's global quality systems and serve as a member of the company's senior leadership team, reporting directly to F. Michael Ball, chief executive officer.

(Photo:  http://photos.prnewswire.com/prnh/20120213/CG52435)

"Zena is a recognized global expert in pharmaceutical quality systems, and her proven experience will help establish quality as a strategic, competitive advantage across our global operations," said Mr. Ball. "Hospira remains fully dedicated to restoring our long-established reputation for the highest-quality products and best possible service for our customers, and I'm confident we now have the right team in place to deliver against these imperatives."

Under Ms. Kaufman's leadership, Hospira will advance its global quality and compliance strategies, drive the continuous improvement of established quality procedures to ensure that processes and products meet high internal standards and regulatory requirements, and ultimately deliver high-quality, cost-effective products to customers.

Ms. Kaufman, who brings 24 years of experience to Hospira, most recently served as divisional vice president, Global Quality Systems, Global Pharmaceutical Operations, for Abbott Laboratories, where her tenure included diverse roles across the company's corporate and divisional quality functions. Prior to Abbott, she held various roles of progressive responsibility in the quality organizations at Pfizer Inc., Pharmacia Corporation and G.D. Searle & Company.

Today, she continues to hold active leadership roles in many industry organizations, including serving on the board of the Parenteral Drug Association as well as having represented Pharmaceutical Research and Manufacturers of America (PhRMA) on the International Conference of Harmonization Guideline: Pharmaceutical Quality Systems.

1 2 3 Next › Last »